Author: Jacob Horowitz

CFTC Chair Rostin Behnam

CFTC Chair Behnam to Resign as President Trump Prepares Pro-Crypto Agenda

Commodity Futures Trading Commission Chair, Rostin Benham, announced that he plans on stepping down from his position as President-elect Trump takes office on January 20th.  Benham served as the CFTC’s chairman for close to three years. He took the position in 2022 after his predecessor resigned when President Biden took Read More

fines against banks declined in 2021

Fifth Circuit Halts Corporate Transparency Act Amid Constitutional Challenge

The United States Court of Appeals for the Fifth Circuit ruled that the Corporate Transparency Act (“CTA”) is once again being put on hold as the court assesses its constitutional validity. The CTA is a law that is purposed for requiring businesses to disclose the identities of their beneficial owners. Read More

Bank of America Settles OCC Cease-and-Desist Order Over Compliance Deficiencies

Bank of America announced that it has settled with the Office of Comptroller of the Currency regarding a cease-and-desist order against the bank for deficiencies related to the Bank Secrecy Act and sanctions compliance programs. The settlement does not require that Bank of America pay a fine but rather take Read More

CFPB Sues Major Banks and Zelle Operator for Alleged Fraud

The Consumer Financial Protection Bureau announced that it has sued Bank of America, JPMorgan, Wells Fargo, and the operator of Zelle, Early Warning Services, for failing to protect consumers from widespread fraud.  Zelle is America’s most widely available payment network. According to the lawsuit, customers of the three banks have Read More

Court Invalidates Nasdaq Board Diversity Requirements

A U.S. Court of Appeals court ruled that Nasdaq can no longer enforce its board diversity rules, vacating the Securities and Exchange Commission’s approval of a rule that requires disclosure of each board member’s racial, gender, and LGBTQ+ identification. The court found that the SEC went beyond the scope of Read More

Looking for hidden Junk Fees

FTC Finalizes Rule that Aims to End Hidden ‘Junk Fees’

The Federal Trade Commission announced that it has finalized a Junk Fees Rule which essentially prohibits businesses in the live-event ticketing and short-term lodging industries from using bait-and-switch pricing and other tactics used to hide total prices and bury “junk fees.” The rule will ensure that pricing information is provided Read More

McKinsey fined for role in opioid crisis

McKinsey To Pay $650 Million to DoJ for Advising Client in Criminal Conduct

G lobal consulting firm McKinsey & Co. has agreed to pay $650 million to settle a Department of Justice investigation into the firm’s consulting work with opioids manufacturer Purdue Pharma. The DoJ had accused McKinsey of fueling the opioid epidemic with its aggressive sales and marketing advice to Purdue, including Read More

The Battle over the Ban of Noncompetes Continues as FTC Receives Unfavorable Ruling

In April 2023, the Federal Trade Commission announced that that it would be banning noncompete agreements in order to promote competition. Although this historic announcement was meant to change the entire landscape of the employment industry within the U.S., the FTC’s push to ban these agreements raised much skepticism from Read More

SEC Cyber Reporting

Equiniti Trust Penalized by SEC for Failing to Protect Client Assets from Cyber Theft

The Securities and Exchange Commission announced that it settled charges against New York-based registered transfer agent Equiniti Trust Company LLC, , for failing to assure that client securities and funds were protected against theft or misuse. Those failures led to the loss of more than $6.6 million of client funds Read More

Humana logo

Humana Settles $90 Million False Claims Act Lawsuit Over Medicare Drug Plan

After an 8-yearlong battle, the insurance giant Humana agreed to pay $90 million to settle claims that it violated the False Claims Act when it submitted fraudulent bids for Medicare prescription drugs contracts. The allegations claim that by misrepresenting the value of its Part D drug plan, also known as Read More